Elite Penny Stocks

Results

20

1 new
Most penny stocks fail because they run out of cash. We handpicked only the most elite penny stocks that have the balance sheets to actually reach their growth targets. If you want to find the next multi-bagger, this is a great place to start.

20 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
NAGE
US$3.433.9%-72.4%US$273.8mUS$12.6014.723.0%n/aHousehold
MNY
US$0.939.3%-10.6%US$41.3mUS$3.000.5156.3%n/aMedia
YSG
US$3.539.6%-65.1%US$325.5mUS$4.000.5146.1%n/aHousehold
MNOV
US$1.439.2%14.4%US$70.4mUS$9.00118.066.7%n/aPharmaceuticals & Biotech
SIGA
US$3.866.9%-42.6%US$276.9mn/a13.794.1%15.5%Pharmaceuticals & Biotech
LFMD
US$4.8716.0%-60.1%US$235.5mUS$9.881.2104.0%n/aHealthcare
FKWL
US$2.48-5.9%-38.4%US$29.9mUS$6.000.874.2%1.6%Tech
KRMD
US$4.605.3%25.3%US$206.2mUS$6.804.993.4%n/aHealthcare
REAX
US$2.2017.0%-46.6%US$465.7mUS$5.150.268.6%n/aReal Estate Management and Development
LSF
New
US$4.89-2.0%-24.5%US$53.8mUS$5.171.0115.9%n/aFood, Beverage & Tobacco
LCTX
US$1.350%42.0%US$336.6mUS$5.5022.872.3%n/aPharmaceuticals & Biotech
MVST
US$1.12-0.9%-67.3%US$373.1mUS$5.501.038.6%n/aCapital Goods
RERE
US$3.97-1.2%4.7%US$877.4mUS$7.5513.931.4%2.5%Retail
CDXS
US$2.6614.2%3.1%US$224.5mUS$6.583.158.1%n/aPharmaceuticals & Biotech
DH
US$0.788.6%-80.7%US$112.1mUS$2.200.388.0%n/aHealthcare
GRAB
US$3.852.9%-22.5%US$16.0bUS$5.9741.423.2%n/aTransportation
NIU
US$2.032.5%-40.6%US$159.2mUS$3.100.284.9%n/aAutomobiles
ZJK
US$1.950.5%-46.9%US$125.4mn/a12.335.7%n/aCapital Goods
FTEK
US$1.85-10.2%-36.2%US$58.3mUS$4.002.265.6%n/aCommercial Services
PPSI
US$3.75-3.8%40.4%US$40.5mUS$9.501.768.6%n/aCapital Goods
Page 1 of 1